Semin intervent Radiol 2024; 41(04): 430-434
DOI: 10.1055/s-0044-1791192

Dan F. Laney IV

1   Section of Interventional Radiology, Department of Radiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana

,

Hector Ferral

1   Section of Interventional Radiology, Department of Radiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana

Biopsy is the gold standard in the diagnosis of diffuse kidney disease.[1] Percutaneous random renal biopsy is a safe and effective method to obtain renal tissue for the diagnosis of diffuse kidney disease.[2] Patients with diffuse kidney disease and multiple comorbidities (morbid obesity, thrombocytopenia, coagulopathies, high blood pressure) may be at higher risk of having a bleeding complication during or after a percutaneous random renal biopsy.[1] If a renal biopsy is imperative to decide a therapeutic approach in high-risk patients, a transjugular renal biopsy (TJRB) may be a safer option.[3]

Halimi et al developed a bleeding risk score for patients with an indication for random renal biopsy.[4] At our institution, we recommend TJRB in patients with a calculated bleeding risk score higher than 15. The purpose of this article is to describe patient selection criteria and procedure techniques for TJRB at our center.

Article published online:
07 November 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA